Review Article - Biomedical Research (2021) Volume 32, Issue 4

India boycotts china: An overview and its effects on indian pharmaceutical industry.

India is the leading country in the production of generic medications but lacks the raw material and the active pharmaceutical ingredients for the manufacturing of the same. About two-third of the API and raw material is imported from China. The Boycott China Moment had a major effect on the imports from China. The objective of this article is to understand how the whole dispute started, why does India rely on China for raw material and API, the problems of setting manufacturing units in India and the effects of the moment on the Indian pharmaceutical industry.

Author(s): Dhruvi Atul Gosar

Abstract Full Text PDF